A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : BOD / burden of disease

[Related PubMed/MEDLINE]
Total Number of Papers: 67
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   BOD  (>> Co-occurring Abbreviation)
Long Form:   burden of disease
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Accounting for long-term manifestations of Cryptosporidium spp infection in burden of disease and cost-of-illness estimations, the Netherlands (2013-2017). COI, DALY, UI, YLDs, YLLs
2019 Diffusely Abnormal White Matter, T2 Burden of Disease, and Brain Volume in Relapsing-Remitting Multiple Sclerosis. DAWM, MS, RRMS
2019 [Disease burden of diabetes attributable to high body mass index in China,1990-2016]. DALY, YLD, YLL
2018 Burden of disease (BoD), disability-adjusted life years (DALY) and frailty prevalence. DALY, FFP, FI, GBD, YLD, YLL
2018 Burden of Disease Due to Secondhand Smoke among Korean Adults at Sub-National Level. CHS, DALYs, PAF, SHS
2018 Outcomes and Predictive Factors of Isolated Limb Infusion for Patients with In-transit Melanoma in China. ALM, CK, CR, ILI, OS, PFS, PR
2018 Predictors of survival in neurometastatic Merkel cell carcinoma. BM, CI, HR, MCC, OS
2017 Burden of Disease Attributable to Smoking in Korea. DALYs, GBD
2017 Burden of disease attributable to vitamin A deficiency in Iranian population aged less than five years: findings from the global burden of disease study 2010. CRA, DALYs, GBD, UI, VAD, YLDs, YLLs
10  2017 Calculation of the disease burden associated with environmental chemical exposures: application of toxicological information in health economic estimation. DALY
11  2017 Disability Weights for Chronic Mercury Intoxication Resulting from Gold Mining Activities: Results from an Online Pairwise Comparisons Survey. CMMVI, DWs, GBD
12  2017 Establishing disability weights for congenital pediatric surgical conditions: a multi-modal approach. DALYs, DWs, PC, TTO, VAS
13  2017 The disease burden of suicide in Ecuador, a 15years' geodemographic cross-sectional study (2001-2015). INEC
14  2016 Accounting for multimorbidity can affect the estimation of the Burden of Disease: a comparison of approaches. CDWs, DALY, DWs, YLD
15  2016 Burden of Disease Attributable to Secondhand Smoking in Korea. DALYs, PAF, SHS
16  2016 Burden of disease of dietary exposure to acrylamide in Denmark. AA, DALY
17  2016 Clinical Response and Regional Toxicity Following Isolated Limb Infusion Compared with Isolated Limb Perfusion for In-Transit Melanoma. CI, HR, ILP, ORR, OS
18  2016 Contributions of national and global health estimates to monitoring health-related sustainable development goals. GHEs, NHEs
19  2016 Health Care Expenditures Associated With Pollution: Exploratory Methods and Findings. LMICs
20  2016 Prognostic factors for long-term outcomes in relapsing-remitting multiple sclerosis. IFN, LTFU, MPR, MS
21  2016 Quantifying Burden of Disease to Measure Population Health in Korea. DALY, GBD
22  2016 Reducing burden of disease from residential indoor air exposures in Europe (HEALTHVENT project). CO, COPD, CV, EEA, EU, PM2.5, VOC, WHO
23  2016 Shedding Light on the "Hidden Psoriasis": A Pilot Study of the Inverse Psoriasis Burden of Disease (IPBOD) Questionnaire. DLQI, IP, IPBOD
24  2016 [Burden of disease attributable to high- sodium diets in China, 2013]. DALY, PAF
25  2015 Burden of disease predicts response to isolated limb infusion with melphalan and actinomycin D in melanoma. ILI, MV, ORR, OS, PFS
26  2015 Disability-adjusted life years lost due to diabetes in France, Italy, Germany, Spain, and the United Kingdom: a burden of illness study. DALYs
27  2015 Disease profile and health-related quality of life (HRQoL) using the EuroQol (EQ-5D + C) questionnaire for chronic metallic mercury vapor intoxication. CMMVI, HRQoL
28  2015 Policy context and narrative leading to the commissioning of the Australian Indigenous Burden of Disease study. IBoD
29  2015 The Burden of Diabetes Mellitus in Patients with Coronary Heart Disease: A Methodological Approach to Assess Quality-Adjusted Life-Years Based on Individual-Level Longitudinal Survey Data. QALYs, QOL
30  2015 The burden of waiting: DALYs accrued from delayed access to pediatric surgery in Kenya and Canada. DALYs
31  2015 [Burden of disease attributable to main behavioral risk factor of chronic disease inactivity in China, 1990 and 2010]. DALY, YLD, YLL
32  2015 [Study on burden of disease in Chongqing, 2010-2013]. DALY, EBOD
33  2014 Disease diagnosis in primary care in Uganda. HMIS, IDCAP
34  2014 Inpatient data, inevitable need for policy making at national and sub-national levels: a lesson learned from NASBOD. HDS
35  2014 National and sub-national environmental burden of disease in Iran from 1990 to 2013-study profile. DALYs, EBD, NASBOD, RFs, YLD, YLL
36  2014 [Burden of disease attributable to road traffic accidents in the Friuli Venezia Giulia Region (Northeastern Italy)]. DALY
37  2013 A square peg in a round hole? Challenges with DALY-based "burden of disease" calculations in surgery and a call for alternative metrics. DALY
38  2013 Burden of disease attributable to the Hebei Spirit oil spill in Taean, Korea. DALY, PTSD, YLD
39  2013 Burden of Disease Studies in the Asia-Pacific Region: Are There Enough being Performed to Provide Information for Evidence-Based Health Policy? AP
40  2013 Putting health metrics into practice: using the disability-adjusted life year for strategic decision making. DALY, FP, PSI
41  2013 Systematic review of foodborne burden of disease studies: quality assessment of data and methodology. DALY
42  2013 The burden of disease related to indoor air in the Netherlands: do different methods lead to different results? CO
43  2012 A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon beta-1b in patients with multiple sclerosis. IFNB, MS, PTH
44  2011 Attributing the burden of cancer at work: three areas of concern when examining the example of shift-work. AFs
45  2011 Burden of disease related to hepatitis C and hepatitis B in Spain: a methodological challenge of an unfolding health problem. DALYs, HBV, HCV, YLD, YLL
46  2011 Economic context analysis in mental health care. Usability of health financing and cost of illness studies for international comparisons. CoI, FoI
47  2011 Measuring the burden of disease using disability-adjusted life years in Shilin County of Yunnan Province, China. DALY, GBD, GIS, Shilin county, WHO, YLD, YLL
48  2010 Applying upstream interventions for interpersonal violence prevention: an uphill struggle in low- to middle-income contexts. ---
49  2009 Hepatitis C and hepatitis B-related mortality in Spain. HCC
50  2009 Rational allocation of Australia's research dollars: does the distribution of NHMRC funding by National Health Priority Area reflect actual disease burden? DALYs, NHMRC, NHPA, YLD, YLL
51  2009 Survey of ENT services in Africa: need for a comprehensive intervention. ENT
52  2009 [Cost of cancer care in Portugal]. CVD, DALY, DRG, USA
53  2008 Reduction in magnetic resonance imaging T2 burden of disease in patients with relapsing-remitting multiple sclerosis: analysis of 48-week data from the EVIDENCE (EVidence of Interferon Dose-response: European North American Comparative Efficacy) study. IFN, IM, MRI, NAbs, RRMS, s.c, tiw
54  2007 What do district health planners in Tanzania think about improving priority setting using 'Accountability for reasonableness'? CEA, PHCI
55  2006 MRI T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability. EDSS, MS
56  2005 Burden of disease related to Parkinson's disease in Spain in the year 2000. BPD, DALY, PD, YLD, YLL
57  2005 The burden of disease, economic costs and clinical consequences of tuberculosis in the Philippines. DALYs, TB, YLL
58  2003 Years of life lost due to premature mortality in Italy. GBD, YLLs
59  2002 Obtaining disability weights in rural Burkina Faso using a culturally adapted visual analogue scale. GBD, VAS
60  2001 Measuring the local burden of disease. A study of years of life lost in sub-Saharan Africa. GBDS, SSA
61  2001 Randomized controlled trial of interferon-beta-1a in secondary progressive MS: MRI results. IFN-beta, SPMS, T1-Gd
62  2001 [Therapeutic potential of interferon beta-1b and related drugs in multiple sclerosis: comparative meta-analysis]. ---
63  2000 An attempt to measure burden of disease using disability adjusted life years for Sri Lanka. DALY
64  2000 Study on measuring burden of disease. DALY
65  2000 [A study on methods to measure the social burden of disease and their significance]. DALY
66  1999 Evidence of interferon beta-1a dose response in relapsing-remitting MS: the OWIMS Study. The Once Weekly Interferon for MS Study Group. CU, PD
67  1994 The relationship between disease and function and perceived health in very frail elders. ADL, SIP